Read More

EXCLUSIVE: VeeCon 2023 ‘Will Be A Bigger, Bolder Event, Think Young Davos Meets SXSW’ — Here’s The Speaker Lineup, Headline Musician

VeeCon is back for a second year and the first round of speakers has been announced ahead of the May 2023 event. Here’s a look at who will be speaking at VeeCon 2023 — and why event founder Gary Vaynerchuk is so excited for the event's second year. 

ETH

Read More

Gilead Presents Proof-Of-Concept Data For Investigational Combination Regimen Of Lenacapavir With Broadly Neutralizing Antibodies As A Potential Twice-Yearly Approach For The Treatment Of HIV

– Study Demonstrates the Potential of Lenacapavir in Combination with Broadly Neutralizing HIV Antibodies Teropavimab and Zinlirvimab – – Findings Support Further Evaluation of the Investigational

GILD

Read More

89bio To Present Additional Pegozafermin Data In Severe Hypertriglyceridemia From Phase 2 ENTRIGUE Study At American College Of Cardiology’s Annual Scientific Session Together With World Congress Of Cardiology

 89bio, Inc. (NASDAQ:ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today

ETNB

Read More

New York’s On The Revel Brings Together Key Players In State’s Beleaguered Cannabis Industry

On The Revel, the parent company for a collection of curated educational and networking experiences democratizing information for those interested in the regulated cannabis industry returns to New York City this month with The Revelry Cannabis Conference — For The People.

CNPOF